For the enterprise leader
Health leaders compared what responsible adoption requires across clinical evidence, workflow integration, patient data, interoperability and continuing oversight.
Experiences · Clinical AI after the pilot
Clinical AI after the pilot
Milan, May 2026 · Private health technology dinner
A past PrompX experience
Healthcare & Pharmaceutical
The question we convened
What evidence should clinical AI provide before a health system can trust it at scale?
In May 2026, PrompX hosted a private dinner in Milan for a healthcare software company entering the Italian market. Six leaders from hospitals, pharmaceutical organisations, clinical operations and digital health joined one technology partner to examine clinical AI evidence, European Health Data Space readiness and the new operational demands around medical technology data.
Two sides of the table
For the technology partner
The healthcare software company heard directly where its proposition matched institutional priorities and what proof was still needed before adoption could move forward.
Inside the conversation
An agenda for the room.
- 01Clinical validation and continuing monitoring for AI used in care
- 02European Health Data Space readiness and secure secondary use of health data
- 03EUDAMED obligations, interoperability and evidence across the product lifecycle
How the experience worked
One question. One carefully composed room.
Each account records the setting, the people brought together and how PrompX helped the most relevant conversations continue.
The setting
A private health technology dinner in Milan in May 2026.
The room
Six senior leaders across hospitals, pharmaceutical organisations, clinical operations and digital health joined one technology partner.
The continuation
Strategic introductions shaped around evidence, data readiness and institutional fit.
Results from the room
Value for both sides of the table.
We asked senior leaders and technology partners whether the room was relevant, useful and worth continuing. We also tracked whether the right conversations continued with partners positioned to help solve the problem.
6 / 6
Senior leaders
Every attending leader said the dinner was relevant to a current clinical technology or health data priority.
1
Technology partner
The invited partner left with a clearer view of the evidence and implementation standards Italian institutions expected.
5 / 6
Continued conversations
Five of six relevant conversations continued after the dinner around live clinical and operational questions.
The PrompX view
“Clinical AI earns access through evidence, workflow understanding and respect for the institution adopting it.”